(-)-Carbovir
Based on 1 Customer Validation
(-)-Carbovir is an active compound.
For research use only. We do not sell to patients.
- Purity: 99.32%
- CAS No.: 120443-30-3
- Formula: C11H13N5O2
- Molecular Weight:247.25
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| C3H/3T3 | CC50 |
>20 μM
Compound: 2
|
Cytostatic concentration required to inhibit C3H/3T3 cell proliferation
Cytostatic concentration required to inhibit C3H/3T3 cell proliferation
|
[PMID: 15887959] |
| C3H/3T3 | EC50 |
6 μM
Compound: 2
|
Effective concentration against murine moloney sarcoma virus in C3H/3T3 cells
Effective concentration against murine moloney sarcoma virus in C3H/3T3 cells
|
[PMID: 15887959] |
| CCRF-CEM | CC50 |
>100 μM
Compound: 5, CBV
|
Cytotoxicity against human CEM cells
Cytotoxicity against human CEM cells
|
[PMID: 19433343] |
| CCRF-CEM | CC50 |
160 μM
Compound: 2
|
Cytostatic concentration required to inhibit CEM cell proliferation
Cytostatic concentration required to inhibit CEM cell proliferation
|
[PMID: 15887959] |
| CCRF-CEM | EC50 |
2 μM
Compound: 2
|
Effective concentration against human immunodeficiency virus type 1 in CEM cells
Effective concentration against human immunodeficiency virus type 1 in CEM cells
|
[PMID: 15887959] |
| CCRF-CEM | EC50 |
2.3 μM
Compound: 2
|
Effective concentration against human immunodeficiency virus type 2 (ROD) in CEM cells
Effective concentration against human immunodeficiency virus type 2 (ROD) in CEM cells
|
[PMID: 15887959] |
| CCRF-CEM | EC50 |
2.3 μM
Compound: 2
|
Effective concentration against human immunodeficiency virus type 2 in CEM cells
Effective concentration against human immunodeficiency virus type 2 in CEM cells
|
[PMID: 15887959] |
| HEL | CC50 |
15 μM
Compound: 2
|
Cytostatic concentration required to inhibit HEL cell proliferation
Cytostatic concentration required to inhibit HEL cell proliferation
|
[PMID: 15887959] |
| HepG2 | CC50 |
150 μM
Compound: 2
|
Cytostatic concentration required to inhibit Hep G2 cell proliferation
Cytostatic concentration required to inhibit Hep G2 cell proliferation
|
[PMID: 15887959] |
| HepG2 | CC50 |
150 μM
Compound: 2
|
Cytostatic concentration required to inhibit Hep G2.2.15 cell proliferation
Cytostatic concentration required to inhibit Hep G2.2.15 cell proliferation
|
[PMID: 15887959] |
| HepG2 2.2.15 | EC50 |
10 μM
Compound: 2
|
Effective concentration againstHBV in Hep G2.2.15 cells
Effective concentration againstHBV in Hep G2.2.15 cells
|
[PMID: 15887959] |
| HepG2 2.2.15 | EC50 |
10.5 μM
Compound: 2
|
Effective concentration against HBV in Hep G2.2.15 cells
Effective concentration against HBV in Hep G2.2.15 cells
|
[PMID: 15887959] |
| Huh-7 | EC50 |
>10 μM
Compound: 5, CBV
|
Antiviral activity against HCV in human Huh7 cells by RNA replicon assay
Antiviral activity against HCV in human Huh7 cells by RNA replicon assay
|
[PMID: 19433343] |
| MT2 | EC50 |
0.19 μg/mL
Compound: 7a (Carbovir)
|
Effective concentration that increases formazan production in infected MT-2 cells
Effective concentration that increases formazan production in infected MT-2 cells
|
[PMID: 2296018] |
| MT2 | IC50 |
41.8 μg/mL
Compound: 7a (Carbovir)
|
Inhibitory concentration that reduces formazan production in infected MT-2 cells.
Inhibitory concentration that reduces formazan production in infected MT-2 cells.
|
[PMID: 2296018] |
| MT4 | IC50 |
4.6 μM
Compound: Carbovir
|
In vitro effective concentration against HIV-1 in MT-4 cells
In vitro effective concentration against HIV-1 in MT-4 cells
|
[PMID: 15916425] |
| P388 | ED50 |
>100 μg/mL
Compound: 7a (Carbovir)
|
Inhibitory concentration of compound for P-388 Leukemia cell culture
Inhibitory concentration of compound for P-388 Leukemia cell culture
|
[PMID: 2296018] |
| PBL | EC50 |
0.03 μM
Compound: 2
|
Effective concentration against human immunodeficiency virus type 1 in PBL cells
Effective concentration against human immunodeficiency virus type 1 in PBL cells
|
[PMID: 15887959] |
| PBMC | CC50 |
7 μM
Compound: 5, CBV
|
Cytotoxicity against human PBMC cells
Cytotoxicity against human PBMC cells
|
[PMID: 19433343] |
| PBMC | EC50 |
0.2 μM
Compound: Carbovir
|
Antiviral activity against lamivudine-resistant HIV1 M184V mutant in human PBMC cells by RT assay
Antiviral activity against lamivudine-resistant HIV1 M184V mutant in human PBMC cells by RT assay
|
[PMID: 17373782] |
| PBMC | EC50 |
0.55 μM
Compound: Carbovir
|
In vitro effective concentration against HIV-1 in human peripheral blood mononuclear cells
In vitro effective concentration against HIV-1 in human peripheral blood mononuclear cells
|
[PMID: 15916425] |
| Vero | CC50 |
>100 μM
Compound: 5, CBV
|
Cytotoxicity against african green monkey Vero cells
Cytotoxicity against african green monkey Vero cells
|
[PMID: 19433343] |
Chemical Information
-
CAS No. 120443-30-3
-
Appearance Solid
-
Molecular Weight 247.25
-
Formula C11H13N5O2
-
SMILES
O=C1C2=C(NC(N)=N1)N([C@@H]3C[C@@H](C=C3)CO)C=N2
-
Synonyms
(-)-NSC 614846
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)